Please assess the completion status of the following clinical trial:

Trial Title: Bronchiectasis and Long Term Azithromycin Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 18 ≥ years~* Bronchiectasis diagnosed by plain bronchography or high resolution computer tomography.~* Minimal 3 lower respiratory tract infections (LRTI) treated with oral/intravenous (IV) antibiotics in the year preceding the study inclusion.~* The presence of chronic respiratory symptoms such as cough, dyspnoea, expectoration of sputum.~* At least one positive sputum culture in the preceding year.~* Informed consent~Exclusion Criteria:~* Previous ( ≥ 4 weeks) prolonged macrolide therapy.~* Pregnant or lactating women.~* Allergy to macrolides.~* Intolerance to macrolides.~* Liver disease (alanine transaminase and/or aspartate transaminase levels 2 or more times the upper limit of normal).~* Use of antibiotics within 14 days of screening.~* Use of oral or IV corticosteroids (≥ 30 mg prednisolone/daily) within 30 days of screening.~* Other research medication started 2 months prior to inclusion.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Azithromycin treatment 1 (Type: ACTIVE_COMPARATOR): None
- Placebo 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).